GLUL is a potential downstream target of miR-183-5p, and OIP5-AS1 enhances cell motility through the upregulation of GLUL by targeting miR-183-5p in nasopharyngeal carcinoma cells [100]. The gene discussed is OIP5; the disease is nasopharyngeal carcinoma.